Selatogrel and Other P2Y12 Inhibitors' Putative Off-Target Effects

J Cardiovasc Pharmacol. 2022 Feb 1;79(2):153-154. doi: 10.1097/FJC.0000000000001135.
No abstract available

Publication types

  • Comment

MeSH terms

  • Organophosphonates*
  • Platelet Aggregation Inhibitors / adverse effects
  • Purinergic P2Y Receptor Antagonists* / adverse effects
  • Pyrimidines
  • Receptors, Purinergic P2Y12

Substances

  • Organophosphonates
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Pyrimidines
  • Receptors, Purinergic P2Y12
  • selatogrel